EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials

Eliya Farah, Matthew Kenney iD, Anris Kica, Paul Haddad, David J Stewart, John-Peter Bradford

Current Oncology · 2023

DOI: 10.3390/curroncol30090603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Eliya Farah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Life-Saving Therapies Network, 173 Heath Street, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: Medical Oncology, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, subject matter experts and healthcare professionals have played a pivotal role in driving oncology clinical trials. Although patients have been key participants, their deliberate and active contribution to the design and decision-making process has been limited. This scoping review aimed to examine the existing literature to scope the extent of active patient engagement in the design of oncology clinical trials and its corresponding influence on trial outcomes. We conducted a systematic search using two databases, namely MEDLINE (Ovid) and EMBASE, to identify relevant studies exploring patient engagement in cancer-related clinical research design. We identified seven studies that met the eligibility criteria. The studies highlighted the benefits of active patient involvement, such as improved recruitment strategies, and the attainment of more patient-centered trial outcomes. The influence of patient involvement varied from tangible developments like patient-friendly resources to indirect impacts like improved patient experiences and potentially higher adherence to trial intervention. The future of clinical trials should prioritize patients’ values and perspectives, with regulatory bodies fostering these practices through clear guidelines. As the concept of patient centricity takes root in oncology research, the involvement of patients should evolve beyond mere participation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical OncologyNeoplasmsHumansDatabases, FactualHealth PersonnelPatient ParticipationClinical Trials as Topic

Stichwörter der Autor:innen

design oncology clinical trialevidence-based patient engagementoncology clinical trialpatient centricity

Autor:innen und Institutionen

  • Life-Saving Therapies Network, 173 Heath Street, Ottawa, ON K1H 8L6, Canada.
  • Department of Medicine, Faculty of Medicine, The Ottawa Hospital, University of Ottawa, 501 Smyth Rd., Ottawa, ON K1H 8L6, Canada.

ORCID-Profile: Matthew Kenney

Zitieren

APA

Farah, E., Kenney, M., Kica, A., Haddad, P., Stewart, D. J., & Bradford, J. P. (2023). Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials. Current Oncology. https://doi.org/10.3390/curroncol30090603

Vancouver

Farah E, Kenney M, Kica A, Haddad P, Stewart DJ, Bradford JP. Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials. Current Oncology. 2023. doi:10.3390/curroncol30090603

BibTeX
@article{Farah2023,
  author = {Farah, Eliya and Kenney, Matthew and Kica, Anris and Haddad, Paul and Stewart, David J and Bradford, John-Peter},
  title = {Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30090603}
}
Kostenlos starten →